5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Adenocarcinoma of the Gastroesophageal Junction

Drug Information

Target Indication

Adenocarcinoma of the Gastroesophageal Junction

Clinical Trial

Last updated: 8/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

RHHBY

Roche Holding AG

Related Pipeline

DLBCL

Melanoma

Breast Cancer

Lung Cancer

Hepatitis C, Chronic

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts